Flowflex SARS-CoV-2 Antigen Rapid Test

Flowflex SARS-CoV-2 Antigen Rapid Test


The Flowflex SARS-CoV-2 Antigen Rapid Test is a rapid lateral flow test used for qualitative detection of SARS-CoV-2 nucleocapsid antigen in anterior nasal swabs taken directly from individuals with suspected COVID-19 infection within the first seven days of symptom onset. Test results are interpreted visually after 15-30 minutes based 

on the presence or absence of colored lines. The intensity of the test lines does not necessarily correspond to the SARS-CoV-2 viral load in the sample.

This test can also be used to test samples of asymptomatic individuals.

The test is performed to identify the presence of SARS-CoV-2 antigen.

This antigen is generally found in upper respiratory tract samples during the acute phase of the infection. A positive result indicates the presence of viral antigens, but individual anamnesis and other diagnostic information are necessary to determine the status of the infection. A positive result does not exclude bacterial infection or co-infection with other viruses. The detected agent may not be the exact cause of the disease.

A negative result in individuals with symptoms that last longer than seven days should be considered to be likely negative. The result should be confirmed by molecular testing, if necessary. A negative result does not rule out SARS-CoV-2 infection. The SARS-CoV-2 Antigen Rapid Test is intended for use as an aid in the diagnosis of SARS-CoV-2 infection. All other clinical data available to the physician should also be considered when interpreting the test results.

This test is intended for in vitro diagnostic use only. The Flowflex SARS-CoV-2 Antigen Rapid Test should only be used for self-testing.

The procedure for performing the test is explained in detail in the Instructions for Use. Read the instructions for use carefully before performing the test. Errors in following the instructions can cause inaccurate test results. Do not eat, drink or smoke before or during the test.

The nasal swab sample can be collected independently by persons above 18 years of age. Children under the age of 18 should be assisted by a parent or legal guardian.

All tests, samples and potentially contaminated materials used to perform the test should be disposed of in accordance with local regulations.

Test accuracy: 98.8%. Test specificity: 99.5%.

Available in pharmacies, in packs of 1 or 5 pcs.

Loading
Loading